Related Experiment Video
Updated: Jun 5, 2026
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
Antiangiogenic potential of three triterpenic acids in human liver cancer cells
Chun-Che Lin1, Chun-Yin Huang, Mei-Chin Mong
1Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung City, Taiwan.
Abstract:
Three triterpenic acids, oleanolic acid, ursolic acid and maslinic acid, at 2 or 4 μmol/L were used to study their antiangiogenic potential in human liver cancer Hep3B, Huh7 and HA22T cell lines. The effects of these compounds upon the level and/or expression of hypoxia-inducible factor (HIF)-1α, basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), interleukin (IL)-8, urokinase plasminogen activator (uPA), reactive oxygen species (ROS), nitric oxide (NO) and cell invasion and migration were examined. Results showed that these triterpenic acids at 4 μmol/L significantly suppressed HIF-1α expression in three cell lines (P < 0.05); and these compounds at test doses failed to affect bFGF expression (P > 0.05). Three triterpenic acids dose-dependently decreased production and expression of VEGF and IL-8, retained glutathione level, lowered ROS and NO levels, and declined cell invasion and migration in test cell lines (P < 0.05). These compounds also dose-dependently reduced uPA production and expression in Hep3B and Huh7 cell lines (P < 0.05); but these agents only at 4 μmol/L significantly suppressed uPA production and expression in HA22T cells (P < 0.05). These findings suggest that these triterpenic acids are potent antiangiogenic agents to retard invasion and migration in liver cancer cells.
Insights
Three triterpenic acids show potent antiangiogenic effects against liver cancer cells. These compounds significantly suppressed key factors like vascular endothelial growth factor (VEGF) and reduced cell invasion and migration.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Liver cancer poses a significant global health challenge.
- Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis.
- Triterpenic acids are natural compounds with potential therapeutic properties.
Purpose of the Study:
- To investigate the antiangiogenic potential of oleanolic acid, ursolic acid, and maslinic acid in human liver cancer cell lines.
- To examine the effects of these triterpenic acids on key angiogenic factors and cellular processes involved in liver cancer progression.
Main Methods:
- Human liver cancer cell lines (Hep3B, Huh7, HA22T) were treated with oleanolic acid, ursolic acid, and maslinic acid at varying concentrations (2 or 4 μmol/L).
- The study assessed the expression and levels of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF), interleukin-8 (IL-8), and urokinase plasminogen activator (uPA).
- Effects on reactive oxygen species (ROS), nitric oxide (NO), glutathione levels, cell invasion, and migration were also evaluated.
Main Results:
- Triterpenic acids significantly suppressed HIF-1α expression and dose-dependently decreased VEGF and IL-8 production and expression.
- These compounds reduced reactive oxygen species (ROS) and nitric oxide (NO) levels, while retaining glutathione levels.
- Cell invasion and migration were significantly inhibited, with dose-dependent reductions in urokinase plasminogen activator (uPA) observed in Hep3B and Huh7 cells.
Conclusions:
- Oleanolic acid, ursolic acid, and maslinic acid demonstrate significant antiangiogenic properties in liver cancer cells.
- These triterpenic acids effectively inhibit key pathways involved in angiogenesis, invasion, and migration.
- The findings suggest potential therapeutic applications of these triterpenic acids in managing liver cancer.
